We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance on manufacturing, importing, distributing and supplying specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials'
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
How to conform with the legal requirements for placing medical devices on the market.
The process for applicants applying for a paediatric investigation plan (PIP) modification or waiver.
Guidance on using non-investigational medicinal products in a clinical trial.
How to register on the MHRA portal and use it to apply for and update marketing authorisations and make other applications.
Who can supply or administer medicines to patients without a doctor under a PGD, which medicines they can supply, and legal requirements for PGDs.
You must include the appropriate legal basis for your application when you apply to MHRA for a marketing authorisation.
How to interpret post-market surveillance (PMS) requirements for medical devices in Great Britain.
Current eAF forms are available for applicants to download and use. Existing submission routes, validation requirements and assessment processes remain unchanged.
How the MHRA makes decisions on what is a medicinal product (borderline products).
Information about medical devices that the public can buy for personal use and how we make sure they are safe and effective.
The eMIT provides information about prices and usage for generic drugs and pharmaceutical products.
Guidance on out of specification investigations, including definitions and laboratory analysis and phase I,II and III investigations.
Detailed guidance on advertising and promoting medicines.
Fees payable to the MHRA from 2025.
Reporting, investigating and recalling suspected defective medicinal products to the Defective Medicines Report Centre (DMRC).
Expressions of interest are invited from AI-enabled medical device manufacturers and NHS provider organisations interested in participating in the London Region I MHRA Regulatory Sandbox.
Information on comparator products used in studies supporting abridged marketing authorisation application.
Guidance on the deadlines for initial and response submissions.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).